ACHISON INC A (ACHN) earnings
Quarterly and annual ACHN reports and results, each read against the price at its own news timestamp. Back to the ACHN overview →
13 measured ACHN earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Antiaging Quantum Living For: Dec 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Antiaging Quantum Living For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Antiaging Quantum Living For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-K Antiaging Quantum Living For: Mar 31 | SEC filing · Form 10-K | — | — | |
| Form NT 10-K Antiaging Quantum Living For: Mar 31 | SEC filing · Form NT | — | — | |
| Form 10-Q Antiaging Quantum Living For: Dec 31 | SEC filing · Form 10-Q | — | — | |
| Form NT 10-Q Antiaging Quantum Living For: Dec 31 | SEC filing · Form NT | — | — | |
| Form 10-Q Antiaging Quantum Living For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Antiaging Quantum Living For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-K/A Antiaging Quantum Living For: Mar 31 | SEC filing · Form 10-K | — | — | |
| Form 10-K Antiaging Quantum Living For: Mar 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q Antiaging Quantum Living For: Dec 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Antiaging Quantum Living For: Sep 30 | SEC filing · Form 10-Q | — | — |
Keep exploring
More ACHN: analyst actions → · SEC filings → · ACHN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SUNESIS PHARMACEUTICALS (SNSS) | 771 | 0.00% | 48% |
| CANCER GENETICS (CGIX) | 769 | -0.08% | 40% |
| OVASCIENCE INC COMMON (OVAS) | 768 | 0.00% | 48% |
| MISONIX, Inc. (MSON) | 760 | 0.00% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.